Novel Rx
1 year ago
Large Chicago study Abs #0535 at #ACR23 biologic tx prescribed more often for males, Non-Hispanic Blacks and Latinx in AS. Low SES, measured by SDI, and insurance status did not affect if pt received bDMARD. https://t.co/MdDuNPMCC9 @rheumnow https://t.co/Oa9aC3rbb0
Since the millennium, we have seen an expansion in the number of advanced treatments both biologic and targeted synthetic disease modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA…
1 year ago
ACR convergence highlights by the awesome, i mean very awesome team @RheumNow
Sunday to Thursday with recap Friday 🤓 i am stocking every one😂
https://t.co/WahAoH7MCM
Biologic / target synthetic induced None melanoma skin cancer? Disease induced or medication induced ?
1 year ago
I never tire of hearing this story.
Biologic DMARDs revolutionized rheumatology & changed millions of lives.
How did we get TNFi?
Sharp translational insights & courage++
After 4w, RA gone, up/down stairs like a miracle.
Sir Ravinder 'Tiny' Maini #ACR23 Global Summit @RheumNow https://t.co/Je1cz3cWG5
In a post hoc analysis of the phase 2 NOBILITY trial, researchers found that treatment with obinutuzumab—an antibody that targets a protein expressed on certain immune cells—was superior to placebo…
1 year ago
Big Pharma – Pay attention! When developing new therapeutics, consider delivery, cost, climate sensitivity and sustainability #GlobalSummit @ACRheum @rheumnow #ACR23 https://t.co/ThqnTI3SNm
1 year ago
Opportunities to address healthcare inequities: generics/biosimilars, fair pricing, and inclusive business models. #GlobalSummit @RheumNow #ACR23 @ACRheum https://t.co/ynJWWcCqWo
Poster Hall